Home
  >  
Section 44
  >  
Chapter 43,717

The stimulation of crystalline lens regeneration in adult tritons

Znoĭko, S.L.; Chagaĭ, A.E.; Mitashov, V.I.; Zhukov, V.G.; Grin, M.A.; Kiziuon, S.M.; Afanasenko, G.A.

Izvestiia Akademii Nauk. Seriia Biologicheskaia 19(3): 346-356

1993

ISSN/ISBN: 1026-3470
PMID: 7686070
Accession: 043716730
Download citation:  
Text
  |  
BibTeX
  |  
RIS
The lens removal from the newt eye stimulates regeneration of the latter from the dorsal iris cells. We have undertaken an attempt to stimulate lens regeneration from teh ventral iris pigmented cells by growth factors: basic and acidic forms of the fibroblast growth factor and the epidermal growth factor. In the presence of the growth factors, the mitotic activity of the ventral iris cells increased 1.5-to 3-fold on the 30th (18) and 70th (58) days after the operation (implantation). Depigmentation of the pupal margin and separation of the ventral iris sheets was observed on the 70th day in teh same animals, what was considered as stage III of lens regeneration. No such stimulation of proliferation was observed in the dorsal iris, but by the 70th day additional lenses have been found to form from the dorsal iris cells.

PDF emailed within 1 workday: $29.90




Related References

2001: An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on influenza vaccination: continued use of Fluviral influenza vaccine in the 2000-2001 season Canada Communicable Disease Report 27: 1-3
2003: An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2003-2004 season Canada Communicable Disease Report 29: 1-20
1998: An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1998-1999 season Canada Communicable Disease Report 24: 1-12
Tam, T.; Langley, J. 2004: An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Update: statement on influenza vaccination for the 2003-04 season Canada Communicable Disease Report 30: 1-5
Orr, P. 2004: An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2004-2005 season Canada Communicable Disease Report 30: 1-32
1996: National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1996-97 season Canada Communicable Disease Report 22(12): 89-97
1990: National Advisory Committee on Immunization (NACI) statement on influenza vaccination for the 1990-1991 season Canada Diseases Weekly Report 16(25): 117-121
2002: An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). Statement on smallpox vaccination Canada Communicable Disease Report 28(Acs-1): 1-12
Tan, B.; Ismail, S. 2010: Varicella Vaccination Two-Dose Recommendations: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 36(Acs-8): 1-26
Campbell, A.; Ismail, S.; Tan, B. 2010: Literature Review on One-Dose and Two-Dose Varicella Vaccination: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 36(Acs-10): 1-24
De Serres, G. 2000: An Advisory Committee Statement (ASC). National Advisory Committee on Immunization (NACI). Statement on adult/adolescent formulation of combined acellular pertussis, tetanus, and diphtheria vaccine Canada Communicable Disease Report 26: 1-8
2000: Statement on alternate adolescent schedule for hepatitis B vaccine (ACS-5). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI) Canada Communicable Disease Report 26: 19-20
1997: An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on hepatitis prevention Canada Communicable Disease Report 23: 1-6
2000: Supplementary statement on hepatitis A vaccine (ACS-4). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI) Canada Communicable Disease Report 26: 12-18
Desai, S.; McGeer, A.; Quach-Thanh, C.; Elliott, D. 2010: Update on the Use of Conjugate Pneumococcal Vaccines in Childhood: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 36(Acs-12): 1-21
Tan, B.; Ismail, S. 2010: Updated Recommendations for the Use of Varicella and MMR Vaccines In HIV-Infected Individuals: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 36(Acs-7): 1-19
Ford-Jones, E.L.; Calvin, S. 2010: Literature Review on Rotavirus: Disease and Vaccine Characteristics: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 36(Acs-14): 1-31
Dawar, D.M.; Harris, M.T.; McNeil, D.S. 2012: Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 38(Acs-1): 1-62
Carter, A.O.; Walsh, P. 1991: National Advisory Committee on Immunization (NACI) statement on universal immunization against hepatitis B Canada Diseases Weekly Report 17(31): 165-171
Gemmill, I. 2003: National Advisory Committee on Immunization (NACI). Statement on thimerosal Canada Communicable Disease Report 29: 1-10